ABCL - Company ID 0001703057
As of 2026-07-11, AbCellera Biologics Inc. (ABCL) has a market capitalization of $2.08 B, making it the #2103 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-07-11 | $2.08 B |
| 2026-07-10 | $2.08 B |
| 2026-07-09 | $2.23 B |
| 2026-07-08 | $2.18 B |
| 2026-07-07 | $2.35 B |
| 2026-07-06 | $2.43 B |
| 2026-07-05 | $2.48 B |
| 2026-07-04 | $2.48 B |
| 2026-07-03 | $2.48 B |
| 2026-07-02 | $2.44 B |
| 2026-07-01 | $2.32 B |
| 2026-06-30 | $2.40 B |
As of 2026-07-11, AbCellera Biologics Inc. (ABCL) has a market capitalization of $2.08 B, making it the #2103 most valuable US-listed company.
AbCellera Biologics Inc. is the #2103 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-06-29 | $2.48 B |
| 2026-06-28 | $2.25 B |
| 2026-06-27 | $2.25 B |
| 2026-06-26 | $2.03 B |
| 2026-06-25 | $1.96 B |
| 2026-06-24 | $1.84 B |
| 2026-06-23 | $1.72 B |
| 2026-06-22 | $1.76 B |
| 2026-06-21 | $1.69 B |
| 2026-06-20 | $1.69 B |
| 2026-06-19 | $1.69 B |
| 2026-06-18 | $1.66 B |
| 2026-06-17 | $1.66 B |
| 2026-06-16 | $1.58 B |
| 2026-06-15 | $1.61 B |
| 2026-06-14 | $1.60 B |
| 2026-06-13 | $1.60 B |
| 2026-06-12 | $1.62 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.